Vijaya Pattabiraman

Company: Bright Peak Therapeutics

Job title: Co-Founder & Chief Technology Officer

Seminars:

Bright Peak Immunoconjugates – A New Class Of Multi-Functional Biologics 1:30 pm

Overviewing Bright Peak’s immunoconjugate platform, designed to upgrade immune checkpoint therapy to the next level An update on BPT567 as the first PD1-IL18 immunoconjugate to enter the clinic Exploring the opportunity for novel biologic activity via Cis signaling with enhanced efficacy and safetyRead more

day: Day Two